5 mg
Trade Name
Omace
Tablet
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Indicated for
- Treatment of hypertension.
- Treatment of symptomatic heart failure.
- Acute myocardial infarction
Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.
- Renal complications of diabetes mellitus
Treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy
- Treatment of hypertension.
- Treatment of symptomatic heart failure.
- Acute myocardial infarction
Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.
- Renal complications of diabetes mellitus
Treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy